Mednow Inc. (MDNWF)
Chart Events
Performance Outlook
| Previous Close | 0.2291 |
| Open | 0.2291 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.2291 - 0.2291 |
| 52 Week Range | 0.2291 - 2.0214 |
| Volume | |
| Avg. Volume | 879 |
| Market Cap | 4.941M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5110 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Mednow’s Liver Care Canada Partners With HepCURE With the Goal of Eliminating Hepatitis C in Canada by 2030
TORONTO, June 29, 2022--Liver Care Canada (a subsidiary of Mednow Inc.) (TSXV: MNOW) (OTCQX:MDNWF), is pleased to announce that it has entered into a partnership agreement with HepCURE, a non-profit company and one of Canada’s leading hepatitis C screening and treatment providers, to achieve the goal of eliminating hepatitis C in Canada by 2030.
- Business Wire
Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth and 4,800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO
TORONTO, June 15, 2022--Mednow Inc. ("Mednow'' or the "Company") (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending April 30th, 2022 ("Q3 2022"). Mednow’s Financial Statements and Management, Discussion & Analysis are available on sedar.com and on the Company’s website, https://investors.mednow.ca.
- Business Wire
Mednow to Present at Gravitas’ 3rd Los Angeles Summit
TORONTO, June 10, 2022--Mednow Inc. ("Mednow'' or the "Company") (TSXV:MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it will be presenting at Gravitas Securities Inc.’s ("Gravitas") 3rd Los Angeles Summit, which will be taking place at the Beverly Hills Hotel from June 21st to June 24th, 2022, in Beverly Hills, California.
